Evidence map›Paper›PMID 15044540›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

Group III metabotropic glutamate receptors maintain tonic inhibition of excitatory synaptic input to hypocretin/orexin neurons.

Claudio Acuna-Goycolea, Ying Li, Anthony N Van Den Pol

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Sleep Deprivation Distinctly Alters Glutamate Transporter 1 Apposition and Excitatory Transmission to Orexin and MCH Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Functions and Mechanisms of Sleep.AIMS neuroscience · 2016
    Article
  11. Review
  12. Leptin acts via lateral hypothalamic area neurotensin neurons to inhibit orexin neurons by multiple GABA-independent mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Claudio Acuna-GoycoleaDepartment of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Ying Li
Anthony N Van Den Pol
Yale University · US

Funding

Hypocretin NeuronsR01NS041454 · NINDS · YALE UNIVERSITY · PI VAN DEN POL, ANTHONY N · 2002 to 2010
$2.9M
GABA: EXCITATORY TRANSMITTER IN DEVELOPING HYPOTHALAMUSR01NS034887 · NINDS · YALE UNIVERSITY · PI VAN DEN POL, ANTHONY N · 1995 to 2008
$2.6M
NINDS NIH HHS NS 34887NINDS NIH HHS NS 41454NINDS NIH HHS R01 NS034887NINDS NIH HHS R01 NS041454
6 · The paper itself

Abstract

Hypocretin/orexin neurons play an important role in hypothalamic arousal. Synaptic glutamate input to hypocretin neurons regulates cell firing. We studied the actions of group III metabotropic glutamate receptors (mGluRs) in modulating the activity of hypocretin neurons using whole-cell voltage- and current-clamp recording in mouse whole hypothalamic slices or minislices consisting only of the lateral hypothalamus. Selective green fluorescent protein expression was used to detect live hypocretin neurons. The mGluR agonist l-(+)-2-amino-4-phosphonobutyric acid (l-AP-4) inhibited synaptic input to hypocretin neurons in a dose-dependent manner; both spontaneous glutamate and GABA-mediated synaptic currents were reduced in frequency. l-AP-4 also reduced the amplitude of postsynaptic potentials evoked by a stimulating electrode placed medial or lateral to the recorded cell. No postsynaptic effect of l-AP-4 was found relative to membrane potential, input resistance, or AMPA-evoked currents. l-AP-4 appeared to act by a presynaptic mechanism and reduced the frequency of both glutamate- and GABA-mediated miniature events recorded in the presence of tetrodotoxin, with no change in amplitude. (RS)-phosphonopentanoic acid (CPPG), a group III mGluR antagonist, suppressed the actions of l-AP-4. Of substantial interest, CPPG by itself increased synaptic activity recorded in hypocretin neurons, suggesting an ongoing inhibitory tone attributable to activation of group III mGluRs. Glutamatergic interneurons have been suggested to play a role in a positive feedback recruitment of hypocretin on hypocretin neurons. l-AP-4 blocked hypocretin-mediated increases in EPSCs and attenuated the hypocretin-mediated increase in spike frequency. Together, these data suggest that tonically active inhibitory mGluRs are expressed on local hypocretin-sensitive glutamate neurons within the lateral hypothalamus that modulate the output of the hypocretin arousal system.

Indexed as

Intracellular Signaling Peptides and ProteinsAction PotentialsAnimalsArousalCarrier ProteinsDose-Response Relationship, DrugElectric StimulationExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsFeedback, PhysiologicalGreen Fluorescent ProteinsHypothalamusIn Vitro TechniquesLuminescent ProteinsMiceCarrier ProteinsExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGreen Fluorescent ProteinsIntracellular Signaling Peptides and ProteinsLuminescent ProteinsNeuropeptidesOrexin ReceptorsOrexinsReceptors, G-Protein-CoupledReceptors, Metabotropic GlutamateReceptors, Neuropeptide

Identifiers

PMID15044540
PMCPMC6729849
OpenAlexW2056060248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.